<DOC>
	<DOCNO>NCT02435004</DOCNO>
	<brief_summary>A prospective , single-arm , mono-centre pilot study obtain preliminary information ability Dorsal Root Ganglion Stimulation ( DRGS ) alleviate painful symptom patient small fiber neuropathy ( SFN ) .</brief_summary>
	<brief_title>Dorsal Root Ganglion Stimulation Management Painful Intractable Small Fibre Neuropathy :</brief_title>
	<detailed_description>This study prospective , single-arm , mono-centre pilot study enrol maximum 31 patient SFN . All enrol patient receive trial neurostimulation ( TNS ) last 3 30 day patient positive result term pain intensity reduction eligible implant neurostimulation ( INS ) phase . The target number patient eligible INS 10 population assess impact DRGS neuropathic pain cause SFN . The expected duration patient participation 14 month . The rationale open label approach novel technique pilot data regard applicability efficacy yet establish . Data gather study provide preliminary data require assess feasibility intervention , use possible future study rigorous methodological approach ( i.e . control trial , randomize controlled trial ) .</detailed_description>
	<mesh_term>Erythromelalgia</mesh_term>
	<criteria>18 year old inclusion Chronic , intractable painful SFN peripheral limb least 12 month biopsy positive SFN , chronic pain intensity â‰¥ 6 Numeric Rating Scale ( range 0 10 ) , previous drug therapy unsuccessful Stable medication dosage 30 day prior inclusion Stable pattern neurological symptom Known suspected noncompliance Drug alcohol abuse Pain predominantly upper limb Neuropathy chronic pain limbs origin SFN Peripheral vascular disease Severe foraminal stenosis expect target level Coagulation disorder Known immunedeficiency Other significant concomitant disease concomitant malignancy Presence indwelling device</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>